Stay updated on MGL-3196 in NASH Patients: Clinical Trial
Sign up to get notified when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.

Latest updates to the MGL-3196 in NASH Patients: Clinical Trial page
- Check2 days agoChange DetectedRevision tag updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. There are no changes to core content, pricing, or other key information.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated to include information on non-alcoholic fatty liver disease, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.6%
- Check17 days agoChange DetectedThe web page has been updated to include new information about the treatment of Fatty Liver Disease, specifically highlighting the drug Resmetirom and its clinical evaluation. Additionally, the facility name and specific locations have been added, while some previous location details and genetic resources have been removed.SummaryDifference5%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to MGL-3196 in NASH Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.